Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Identify which index fund to hold after IRA rollover 2024 by weighing cost, simplicity, and diversification. Get practical guidance for a solid retirement stance.
26,517 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
Bitcoin hovers near a pivotal zone as bulls and bears clash. Analysts warn of a potential break below key supports, s...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
Aging homeowners are turning estate sales into a routine part of listings, prompting a need for a formal checklist re...
Boot Barn stands at a crossroads in 2026. This guide breaks down the growth drivers, potential risks, and practical i...
A risk-off mood is weighing on major cryptos as ETF redemptions surge. This guide breaks down the forces at work and ...
Whales keep piling into Bitcoin as volatility persists. A rising number of 100+ BTC wallets points to sustained inter...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Rapid shifts in freight markets are driving the SonicShares Global Shipping ETF's payouts. Here are the two rates boa...
When personal drama collides with headlines, your wallet should still stay protected. This article distills the Stefo...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...